![](/img/cover-not-exists.png)
P286 Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment
M. Gnant, B. Mlineritsch, H. Stoeger, G. Luschin-Ebengreuth, D. Heck, G. Steger, R. Jakesz, C. Singer, P. Dubsky, R. GreilVolume:
20
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/s0960-9776(11)70228-4
File:
PDF, 38 KB
english, 2011